January 19, 2022
Zogenix, Inc. Investigation
We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Zogenix, Inc. (“Zogenix” or the “Company”) (NASDAQ:ZGNX), in connection with the proposed acquisition of the Company by UCB S.A.(“UCB”) (Euronext: UCB) via a tender offer. Under the terms of the acquisition agreement, the Company’s shareholders will receive $26.00 in cash, plus a contingent value right for a potential cash payment of $2.00, for each share of Zogenix common stock that they hold.
Join Case →